Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Operating Expenses

$9.21B

TTM · Period ending: Jun 30, 2026 · USD

REGN Operating Expenses

Latest reported$9.21Bperiod endingJun 30, 2026

Latest reported$9.21Bperiod endingJun 30, 2026

REGN TTM Operating Expenses (-$8.30M → $9.21B)

TTM operating expenses

High-resolution chart · PNG

REGN operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	77,979,000
Mar 31, 2001	73,166,000
Dec 31, 2000	70,257,000
Sep 30, 2000	62,569,000
Jun 30, 2000	60,993,000
Mar 31, 2000	56,927,000
Dec 31, 1999	54,500,000
Sep 30, 1999	54,000,000
Jun 30, 1999	50,500,000
Mar 31, 1999	49,000,000
Dec 31, 1998	46,000,000
Sep 30, 1998	43,300,000
Jun 30, 1998	40,600,000
Mar 31, 1998	38,800,000
Dec 31, 1997	38,100,000
Sep 30, 1997	38,700,000
Jun 30, 1997	40,100,000
Mar 31, 1997	40,200,000
Dec 31, 1996	40,300,000
Sep 30, 1996	38,900,000
Jun 30, 1996	36,900,000
Mar 31, 1996	35,900,000
Dec 31, 1995	35,000,000
Sep 30, 1995	39,300,000
Jun 30, 1995	43,300,000
Mar 31, 1995	48,000,000
Dec 31, 1994	52,400,000
Sep 30, 1994	82,200,000
Jun 30, 1994	71,900,000
Mar 31, 1994	69,400,000
Dec 31, 1993	67,300,000
Sep 30, 1993	33,100,000
Jun 30, 1993	38,800,000
Mar 31, 1993	34,400,000
Dec 31, 1992	29,800,000
Sep 30, 1992	22,100,000
Jun 30, 1992	16,100,000
Mar 31, 1992	10,200,000
Dec 31, 1991	3,500,000
Sep 30, 1991	-5,500,000
Jun 30, 1991	-7,500,000
Mar 31, 1991	-8,300,000
Dec 31, 1990	-8,300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.